- Products
- Reproduction
- Molecular diagnostics
- Careers
- About us
- Contacts
NGS panels for the detection of somatic variants by analyzing ctDNA from blood plasma using AMP technology
Kits for detection of EGFR, KRAS, NRAS gene mutations by cfDNA analysis using PANAMutyper™ technology.
A kit for the detection of 15 biomarkers for the early detection of bladder cancer by analysis of DNA isolated from urine
Detection of germline and somatic SNVs and CNVs in the BRCA1 and BRCA2 genes
Detection of germline mutations in 12 genes associated with breast and ovarian tumor syndromes by amplicon sequencing.
Detection of germline mutations in 10 genes incl. differentiation of PMS2 gene variants and PMS2CL pseudogene
Detection of somatic SNV and InDel mutations in 42 genes using NGS.
Detection of SNV, InDel and CNV germline mutations in 35-144 genes using NGS.
Reliable and effective CNV analysis of 28 genes using unique digitalMLPA technology
Detection of germline and somatic mutations in BRCA1, BRCA2, PALB2 genes.
Detection of SNV, InDel and CNV germline mutations in 26 genes using NGS.
Detection of somatic SNV and InDel mutations in 42 genes and 137 gene fusions by NGS.
NGS panels for the detection of SNVs, InDels and CNVs in 4-28 HRR genes.
NGS RNA panels for the detection of SNVs, InDels and gene fusions even with unknown binding partners.
NGS panel for detection of SNVs, InDels and CNVs in 477 genes. It also allows determination of MSI and TMB.
Kits for determining the risk of developing cervical cancer using the bisulfite reaction and rtPCR.
Kits for detection of EGFR, KRAS, NRAS, BRAF gene mutations by PNAClamp technology
NGS solution for detection of variants of 28 HRR genes and determination of genomic integrity to determine HRD status.
NGS DNA panels for the detection of SNV, InDel and CNV somatic variants using AMP technology
NGS RNA panels for the detection of gene fusions, alternative splicing, SNV and InDel variants using AMP technology
Reliable and efficient CNV analysis using the unique digitalMLPA technology with >600 probes that target multiple myeloma-related regions.
Reliable and efficient CNV analysis using the unique digitalMLPA technology with >700 probes that target ALL-associated regions.
Kit detecting a panel of eleven gene fusions associated with acute myeloid leukemia in a single PCR reaction.
NGS DNA panels for the detection of SNV, InDel and CNV somatic variants using AMP technology
NGS RNA panels for the detection of gene fusions, alternative splicing, SNV and InDel variants using AMP technology
NGS panel for the detection of SNV, InDel and CNV somatic variants using hybrid capture technology.
NGS panel for the detection of somatic variants and gene fusions using hybrid capture technology.
NGS panel for the detection of SNV, InDel and CNV somatic variants using hybrid capture technology.
NGS panel for the detection of somatic variants and clonality using hybrid capture technology.
NGS panel for the detection of SNV and InDel somatic variants using hybrid capture technology.
Kit enabling qualitative and quantitative detection of 12 STR markers for monitoring chimerism after HSCT.
Kit enabling the qualitative detection of 33 DIP markers suitable for monitoring chimerism after HSCT.
Kit enabling the qualitative detection of 33 DIP markers suitable for monitoring chimerism after HSCT.
A pair of kits enabling qualitative and quantitative detection of DIP-markers for chimerism monitoring using digitalPCR.
NGS panel enabling detection of B and T cell clonality, IG and TCR rearrangements, translocations and mutations in 82 genes for comprehensive testing of lymphoproliferative diseases.
Genetic test for prenatal diagnosis of aneuploidy of chromosomes 13, 18, 21, X and Y based on QF-PCR technology using 26 markers.
Genetic test for prenatal diagnosis of aneuploidy of chromosomes 13, 18, 21, X and Y based on QF-PCR technology using 33 markers.
Genetic test for prenatal diagnosis of aneuploidy of chromosomes 13, 15, 16, 18, 21, 22, X and Y based on QF-PCR technology.
Genetic test for prenatal diagnosis of aneuploidy of chromosomes 13/18/21/XY based on QF-PCR technology.
Genetic test for prenatal diagnosis of uniparental disomy of chromosome 15 based on QF-PCR technology.
Tests for the detection of microdeletions in the AZFa, AZFb and AZFc regions of the Y chromosome.
Kits detecting TREC, KREC and SMN1 for newborn screening of SCID, XLA and SMA by rtPCR.
Product for the detection of 36 CFTR gene mutations most common in the European population and polyT/TG repeats in intron 9.
Product for the detection of 68 CFTR gene mutations and polyT/TG repeats in intron 9.
NGS kit for the detection of SNV, InDel and CNV variants in the CFTR gene.
One single mix for testing of six relevant risk factors for thrombophilia.
A test for the detection of the 7 most common variants associated with the risk of developing cardiovascular diseases in one reaction mixture.
Kit enabling the simultaneous detection of the 3 most frequent mutations and the corresponding WT variants in the HFE gene.
NGS kit for the identification of 12 SNPs in polygenic FH & the 6 SNPs to predict statin response.
Kits for the detection of the two most common FII G20210A and FVL G1691A variants associated with the risk of thrombosis.
Kits for the detection of two variants of the MTHFR gene associated with the risk of thrombosis using LAMP technology.
Product for the detection of 4G/5G polymorphism in the promoter of the PAI-1 gene associated with the risk of thrombosis using LAMP technology.
NGS kit for the detection of variants in the genes HBA1, HBA2, HBB and 17 other CNVs associated with thalassemia.
Kit for fetal RhD status determination by non-invasive analysis of fetal cfDNA isolated from maternal plasma using rtPCR.
Test for the detection of 3 alleles of the TPMT gene affecting the metabolism of thiopurine drugs using LAMP technology.
Test for the detection of 4 alleles of the DPYD gene affecting the metabolism of fluoropyrimidine drugs using LAMP technology.
Test for the detection of 2 alleles of the CYP2C9 gene affecting the metabolism of important drugs using LAMP technology.
Test for the detection of 3 alleles of the CYP2C19 gene affecting the metabolism of important drugs using LAMP technology.
NGS panel for the detection of variants in 41 genes important from the point of view of pharmacogenomics using hybrid capture technology.
NGS panel for clinical exome sequencing, which enables the detection of SNV, InDel and CNV variants in 5500 genes using hybrid capture technology.
NGS panel for whole exome sequencing, which enables the detection of SNV, InDel and CNV variants in 19 425 genes using hybrid capture technology.
NGS panel enabling the detection of SNV, InDel and CNV variants in 31 genes associated with arrhythmias and cardiomyopathies using hybrid capture technology.
NGS panel enabling the detection of SNV, InDel and CNV variants in 128 genes associated with arrhythmias and cardiomyopathies using hybrid capture technology.
NGS panel enabling the detection of SNVs, InDels and CNVs in 44 genes associated with nephropathies using hybrid capture technology.
NGS panel for detection of SNVs, InDels and CNVs in 569 genes using hybrid capture technology.
Kits for the detection of the most common polymorphisms associated with lactose intolerance in adulthood using LAMP technology.
Kit for the detection of DQA1*05, DQB1*02 and DQB1*0302 alleles associated with celiac disease using LAMP technology.
Kit for detection of the most common polymorphism associated with hereditary fructose intolerance using LAMP technology.
Kits for the detection of HLA-B27 alleles and polymorphism for the diagnosis of ankylosing spondylitis using LAMP technology.
Kit for detecting the two most common variants in the HFE gene using LAMP technology.
Kit for detection of two SERPINA1 alleles associated with alpha-1 antitrypsin deficiency using LAMP technology.
Kit for the detection of two alleles (hemoglobin S and C) associated with the risk of sickle cell disease using LAMP technology.
Kit for quantification of the number of CGG repeats (<120) of the FMR1 gene for diagnosis of Fragile X syndrome.
Kit for quantification of the number of CGG repeats (<220) of the FMR1 gene for diagnosis of Fragile X syndrome.
Kit for the amplification of the CAG polymorphic repetition in the genes ATXN1, ATXN2, ATXN3, CACNA1A and ATXN7 associated with spinocerebellar ataxias types 1, 2, 3, 6 and 7.
Kits for the diagnosis of respiratory, infectious and sexually transmitted diseases as well as the detection of food pathogens based on rtPCR.
FISH probes with shortened hybridization and high specificity for pathology and hemato-oncology.
A new medium for the rapid cultivation of chorionic tissue, spontaneous abortions and cells from amniotic fluid.
A new medium for the rapid cultivation of chorionic tissue, spontaneous abortions and cells from amniotic fluid.
Medium specially developed for hypotonia. The application of Flushing media ensures a subsequent high-quality cultivation result.
Medium for the cultivation of bone marrow cells and leukemic blood cells.
Special medium for the cultivation of lymphocytes from peripheral blood.
Mitosis arresting product of cultured cells in metaphase.
SALSA® MLPA® is the gold standard for the quantification of copy numbers. Up to 60 different genomic DNA sequences can be quantified simultaneously.
This SALSA® Melt Assay is based on high-resolution melt curve analysis to identify specific allelic variants that may be associated with SMA.
An ELISA-based donor-specific HLA Crossmatch for antibodies against HLA-A, -B, -C, -DRB1, -DQB1, -DQA1 and -DPB1.
NGS systems for easy and efficient HLA typing.
A system for HLA typing of alleles associated with celiac disease.